Titulo:
Expresión de STAT3 y respuesta a pirimetamina en un glioblastoma.
.
Sumario:
.
Guardado en:
2256-2877
2256-2915
2
2013-03-01
49
50
Andrés Felipe Cardona - 2013
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_acho_revistacolombianadehematologiayoncologia_27_article_331 |
|---|---|
| record_format |
ojs |
| spelling |
Expresión de STAT3 y respuesta a pirimetamina en un glioblastoma. STAT3 expression and pyrimethamine response in a glioblastoma. . Cardona, Andrés Felipe Quintero, Andrés Useche, Nicolás Bermúdez, Sonia Jiménez, Enrique Hakim, Fernando Ortiz, León Darío 2 1 Núm. 1 , Año 2013 : Marzo Artículo de revista Journal article 2013-03-01T00:00:00Z 2013-03-01T00:00:00Z 2013-03-01 application/pdf Asociación Colombiana de Hematología y Oncología (ACHO) Revista Colombiana de Hematología y Oncología 2256-2877 2256-2915 https://revista.acho.info/index.php/acho/article/view/331 10.51643/22562915.331 https://doi.org/10.51643/22562915.331 spa https://creativecommons.org/licenses/by-nc-sa/4.0 Andrés Felipe Cardona - 2013 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. 49 50 Cooper LA, Gutman DA, Chisolm C, Appin C, Kong J, Rong Y, et al. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am J Pathol. 2012;180(5):2108-19. Takakura A, Nelson EA, Haque N, Humphreys BD, Zandi-Nejad K, Frank DA, et al. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum Mol Genet. 2011;20(21):4143-54. Kohsaka S, Wang L, Yachi K, Mahabir R, Narita T, Itoh T, et al. STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression. Mol Cancer Ther. 2012;11(6):1289-99. Chen M, Osman I, Orlow SJ. Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells. Mol Cancer Res. 2009;7(5):703-12. Giammarioli AM, Maselli A, Casagrande A, Gambardella L, Gallina A, Spada M, et al. Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism. Cancer Res. 2008;68(13):5291-300. Bid HK, Oswald D, Li C, London CA, Lin J, Houghton PJ. Antiangiogenic activity of a small molecule STAT3 inhibitor LLL12. PLoS One. 2012;7(4):e35513. De Groot JF, Liang J, Kong LY, Wei J, Piao Y, Fuller G, et al. Modulation of antiangiogenic resistance: Targeting the JAK/ STAT3 pathway in glioblastoma. J Clin Oncol. 2012;30 (suppl; abstr 2011). Parsa AT. A newly identified transcriptional network for mesenchymal transformation of brain tumors: potential targets for therapeutic intervention. World Neurosurg. 2010;73(5):424. https://revista.acho.info/index.php/acho/article/download/331/297 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/redcol/resource_type/ARTREF info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication |
| institution |
ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA |
| thumbnail |
https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png |
| country_str |
Colombia |
| collection |
Revista Colombiana de Hematología y Oncología |
| title |
Expresión de STAT3 y respuesta a pirimetamina en un glioblastoma. |
| spellingShingle |
Expresión de STAT3 y respuesta a pirimetamina en un glioblastoma. Cardona, Andrés Felipe Quintero, Andrés Useche, Nicolás Bermúdez, Sonia Jiménez, Enrique Hakim, Fernando Ortiz, León Darío |
| title_short |
Expresión de STAT3 y respuesta a pirimetamina en un glioblastoma. |
| title_full |
Expresión de STAT3 y respuesta a pirimetamina en un glioblastoma. |
| title_fullStr |
Expresión de STAT3 y respuesta a pirimetamina en un glioblastoma. |
| title_full_unstemmed |
Expresión de STAT3 y respuesta a pirimetamina en un glioblastoma. |
| title_sort |
expresión de stat3 y respuesta a pirimetamina en un glioblastoma. |
| title_eng |
STAT3 expression and pyrimethamine response in a glioblastoma. |
| description |
.
|
| author |
Cardona, Andrés Felipe Quintero, Andrés Useche, Nicolás Bermúdez, Sonia Jiménez, Enrique Hakim, Fernando Ortiz, León Darío |
| author_facet |
Cardona, Andrés Felipe Quintero, Andrés Useche, Nicolás Bermúdez, Sonia Jiménez, Enrique Hakim, Fernando Ortiz, León Darío |
| citationvolume |
2 |
| citationissue |
1 |
| citationedition |
Núm. 1 , Año 2013 : Marzo |
| publisher |
Asociación Colombiana de Hematología y Oncología (ACHO) |
| ispartofjournal |
Revista Colombiana de Hematología y Oncología |
| source |
https://revista.acho.info/index.php/acho/article/view/331 |
| language |
spa |
| format |
Article |
| rights |
https://creativecommons.org/licenses/by-nc-sa/4.0 Andrés Felipe Cardona - 2013 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 |
| references |
Cooper LA, Gutman DA, Chisolm C, Appin C, Kong J, Rong Y, et al. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am J Pathol. 2012;180(5):2108-19. Takakura A, Nelson EA, Haque N, Humphreys BD, Zandi-Nejad K, Frank DA, et al. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum Mol Genet. 2011;20(21):4143-54. Kohsaka S, Wang L, Yachi K, Mahabir R, Narita T, Itoh T, et al. STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression. Mol Cancer Ther. 2012;11(6):1289-99. Chen M, Osman I, Orlow SJ. Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells. Mol Cancer Res. 2009;7(5):703-12. Giammarioli AM, Maselli A, Casagrande A, Gambardella L, Gallina A, Spada M, et al. Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism. Cancer Res. 2008;68(13):5291-300. Bid HK, Oswald D, Li C, London CA, Lin J, Houghton PJ. Antiangiogenic activity of a small molecule STAT3 inhibitor LLL12. PLoS One. 2012;7(4):e35513. De Groot JF, Liang J, Kong LY, Wei J, Piao Y, Fuller G, et al. Modulation of antiangiogenic resistance: Targeting the JAK/ STAT3 pathway in glioblastoma. J Clin Oncol. 2012;30 (suppl; abstr 2011). Parsa AT. A newly identified transcriptional network for mesenchymal transformation of brain tumors: potential targets for therapeutic intervention. World Neurosurg. 2010;73(5):424. |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2013-03-01 |
| date_accessioned |
2013-03-01T00:00:00Z |
| date_available |
2013-03-01T00:00:00Z |
| url |
https://revista.acho.info/index.php/acho/article/view/331 |
| url_doi |
https://doi.org/10.51643/22562915.331 |
| issn |
2256-2877 |
| eissn |
2256-2915 |
| doi |
10.51643/22562915.331 |
| citationstartpage |
49 |
| citationendpage |
50 |
| url2_str_mv |
https://revista.acho.info/index.php/acho/article/download/331/297 |
| _version_ |
1811200923034189824 |